Source: International Congress 2016 – Molecular immunology of the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Takamitsu Asano (Nagoya, Japan), Takamitsu Asano, Yoshihiro Kanemitsu, Masaya Takemura, Makoto Yokota, Kensuke Fukumitsu, Norihisa Takeda, Hiroya Ichikawa, Shoichiro Ohta, Yoshihisa Nakamura, Kenji Izuhara, Motohiko Suzuki, Akio Niimi. LATE-BREAKING ABSTRACT: Serum periostin as a valuable biomarker of comorbid chronic rhinosinusitis in patients with asthma. Eur Respir J 2016; 48: Suppl. 60, 4951

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Usefulness of periostin as a biomarker of pediatric asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Serum periostin in healthy controls and patients with asthma and chronic rhinosinusitis; data from the Swedish GA(2)LEN population study Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Refined severity assessment of asthmatic children using molecular allergy diagnostics Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Nasal symptoms and doctor-diagnosed chronic lung diseases Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013